Themis Collaborates With Abl Europe In France On The Production Of Its Sars Cov-2 Vaccine Candidate

Themis Collaborates With Abl Europe In France On The Production Of Its Sars Cov-2 Vaccine Candidate

By, Admin 13 May 2020

Themis , A Biopharmaceutical Company With Clinical Development Programs Focused On Immunomodulation Therapies For Infectious Diseases And Cancer , And Abl Europe ( Abl ), Global Contract Development And Manufacturing Organization ( Cdmo ), Contract Research Institute ( Cro) And Subsidiary Of The French Biotechnology Group Institut MÉRieux, Announced Today That Abl Will Produce A Themis Vaccine Candidate In Preparation For Planned Clinical Trials. The Vaccine Is Developed Using A Measles Virus-Based Vaccine Platform, Which Is Licensed Exclusively To Themis By The World-Famous Pasteur Institute In Paris .Dr. Erich Tauber , Ceo Of Themis , Commented: &Ldquo;The Main Reasons Why We Decided To Work With Abl Europe Are Based On Our Previous Experience With The Company And Its Virological Expertise. Abl Has A Significant Advantage When It Comes To Fast Production. This Means That We Can Start Our Clinical Trials Quickly. "Themis Recently Announced That It Is Actively Working With The Pasteur Institute, The Center For Vaccine Research At The University Of Pittsburgh And The Coalition For Epidemic Preparedness Innovations (Cepi) To Develop A Covid-19 Vaccine Candidate. To Date, Cepi Has Invested $ 4.9 Million In This Vaccine Development. Abl Was Selected By Themis As The Manufacturer And Supplier Of The Covid-19 Vaccine Candidate To Be Used For Clinical Trials.&Ldquo;We Consider It A Privilege To Be Able To Work With Themis In The Global Fight Against The Covid-19 Pandemic. In This Specific Situation, We At Abl Will Use Our Know-How To Quickly Bring A Promising Vaccine Candidate Into Clinical Trials, "Said Dr. Patrick Mahieux , Managing Director Of Abl Europe.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!